Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Update of the position paper of the Spanish Society of Rheumatology on biosimilar drugs
Miguel Ángel Abad Hernández; José Luis Andreu; Alejandro Balsa Criado; Federico Díaz-González; José Vicente Moreno Muelas; Rubén Queiro Silva; Juan J. Gómez-Reino;
Reumatol Clin. 2021;17:160-9
Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain
Emilio Monte-Boquet; Ángeles Florez; Guillermo José Alcaín Martínez; Agustí Sellas;
Reumatol Clin. 2023;19:446-54
Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis
José Rosas; María Martín-López; Teresa Otón; Alejandro Balsa; Jaime Calvo-Alén; Raimon Sanmartí; Jesús Tornero; Loreto Carmona;
Reumatol Clin. 2020;16P2:378-85